{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T22:29:08Z","timestamp":1784413748134,"version":"3.55.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23 MH064619"],"award-info":[{"award-number":["K23 MH064619"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH070553"],"award-info":[{"award-number":["R01 MH070553"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K05MH069124"],"award-info":[{"award-number":["K05MH069124"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL073921"],"award-info":[{"award-number":["R01HL073921"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01MH075102"],"award-info":[{"award-number":["R01MH075102"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 MH020018"],"award-info":[{"award-number":["T32 MH020018"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008374","name":"Emory Center for AIDS Research","doi-asserted-by":"crossref","award":["P30 AI050409"],"award-info":[{"award-number":["P30 AI050409"]}],"id":[{"id":"10.13039\/100008374","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Clinical and Translational Science Award Program","award":["UL1 RR025008"],"award-info":[{"award-number":["UL1 RR025008"]}]},{"name":"General Clinical Research Center Program, National Institutes of Health, National Center for Research Resources","award":["M01 RR0039"],"award-info":[{"award-number":["M01 RR0039"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology &amp; Behavior"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.physbeh.2015.12.013","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T11:43:04Z","timestamp":1450438984000},"page":"14-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus"],"prefix":"10.1016","volume":"166","author":[{"given":"Jennifer C.","family":"Felger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Haroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobbi J.","family":"Woolwine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Raison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2015.12.013_bb0005","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.psyneuen.2003.11.003","article-title":"Flattened cortisol rhythms in metastatic breast cancer patients","volume":"29","author":"Abercrombie","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4088\/JCP.v65n0420b","article-title":"Ribavirin may be an important factor in IFN-induced neuropsychiatric effects","volume":"65","author":"Asnis","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0015","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00006842-200207000-00010","article-title":"Fatigue and proinflammatory cytokine activity in breast cancer survivors","volume":"64","author":"Bower","year":"2002","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.psyneuen.2004.06.003","article-title":"Diurnal cortisol rhythm and fatigue in breast cancer survivors","volume":"30","author":"Bower","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bbi.2010.09.010","article-title":"Fatigue and gene expression in human leukocytes: increased NF-kappaB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue","volume":"25","author":"Bower","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0030","series-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology","first-page":"2384","article-title":"Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy","volume":"32","author":"Capuron","year":"2007"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0035","doi-asserted-by":"crossref","first-page":"E56","DOI":"10.1002\/oby.20047","article-title":"Diurnal salivary cortisol is associated with body mass index and waist circumference: the Multiethnic Study of Atherosclerosis","volume":"21","author":"Champaneri","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0040","doi-asserted-by":"crossref","first-page":"R189","DOI":"10.1186\/gb-2007-8-9-r189","article-title":"Social regulation of gene expression in human leukocytes","volume":"8","author":"Cole","year":"2007","journal-title":"Genome Biol."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0045","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/156720507780362236","article-title":"Glucocorticoids, the etiology of obesity and the metabolic syndrome","volume":"4","author":"Dallman","year":"2007","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0050","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.psyneuen.2007.10.007","article-title":"Interleukin-1 receptor type 1-deficient mice fail to develop social stress-associated glucocorticoid resistance in the spleen","volume":"33","author":"Engler","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biopsych.2005.05.001","article-title":"Mood disorders in the medically ill: scientific review and recommendations","volume":"58","author":"Evans","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0065","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.bbi.2011.02.015","article-title":"Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue","volume":"25","author":"Felger","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0070","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1017\/S0033291711002868","article-title":"Molecular signatures of peripheral blood mononuclear cells during chronic interferon-alpha treatment: relationship with depression and fatigue","volume":"42","author":"Felger","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0075","first-page":"1","article-title":"Molecular signatures of peripheral blood mononuclear cells during chronic interferon-alpha treatment: relationship with depression and fatigue","author":"Felger","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2012.10.010","article-title":"Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations","volume":"31","author":"Felger","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0085","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","article-title":"Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications","volume":"246","author":"Felger","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0090","series-title":"Structured Clinical Interview for DSM-IV","author":"First","year":"1997"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0095","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1037\/0278-6133.23.6.645","article-title":"Repression and high anxiety are associated with aberrant diurnal cortisol rhythms in women with metastatic breast cancer","volume":"23","author":"Giese-Davis","year":"2004","journal-title":"Health Psychol."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/npp.2011.205","article-title":"Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior","volume":"37","author":"Haroon","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/neuro.08.041.2009","article-title":"Effect of childhood trauma on adult depression and neuroendocrine function: sex-specific moderation by CRH receptor 1 gene","volume":"3","author":"Heim","year":"2009","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0110","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.biopsych.2007.07.002","article-title":"The dexamethasone\/corticotropin-releasing factor test in men with major depression: role of childhood trauma","volume":"63","author":"Heim","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0120","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.bbi.2009.01.001","article-title":"Interferon-alpha inhibits glucocorticoid receptor-mediated gene transcription via STAT5 activation in mouse HT22 cells","volume":"23","author":"Hu","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0125","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0006-3223(97)80434-9","article-title":"The dexamethasone suppression test and sleep electroencephalogram in nonbipolar major depressed inpatients: a multivariate analysis","volume":"43","author":"Hubain","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0130","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.biopsycho.2013.01.018","article-title":"Dysregulated diurnal cortisol pattern is associated with glucocorticoid resistance in women with major depressive disorder","volume":"93","author":"Jarcho","year":"2013","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0135","first-page":"E114","article-title":"Differential release of tumor necrosis factor and IL-6 from adrenal zona glomerulosa cells in vitro","volume":"268","author":"Judd","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0140","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jad.2014.06.001","article-title":"Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study","volume":"167","author":"Lopresti","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0145","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/01.psy.0000244071.42939.0e","article-title":"Diurnal cortisol decline is related to coronary calcification: CARDIA study","volume":"68","author":"Matthews","year":"2006","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/da.22084","article-title":"Cytokine targets in the brain: impact on neurotransmitters and neurocircuits","volume":"30","author":"Miller","year":"2013","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0155","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.biopsych.2008.03.017","article-title":"A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling","volume":"64","author":"Miller","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0160","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1200\/JCO.2005.04.2838","article-title":"Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients","volume":"24","author":"Monk","year":"2006","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0165","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0170","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM200103293441303","article-title":"Paroxetine for the prevention of depression induced by high-dose interferon alfa","volume":"344","author":"Musselman","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0175","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1176\/appi.ajp.158.8.1252","article-title":"Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings","volume":"158","author":"Musselman","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbi.2015.02.002","article-title":"Insufficient glucocorticoid signaling and elevated inflammation in coronary heart disease patients with comorbid depression","volume":"48","author":"Nikkheslat","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbi.2006.08.009","article-title":"Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression","volume":"21","author":"Pace","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0190","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.bbi.2011.07.227","article-title":"Activation of cAMP-protein kinase A abrogates STAT5-mediated inhibition of glucocorticoid receptor signaling by interferon-alpha","volume":"25","author":"Pace","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0195","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0006-3223(00)01088-X","article-title":"Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment","volume":"49","author":"Pariante","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0200","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1210\/endo.140.9.6986","article-title":"The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function","volume":"140","author":"Pariante","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0205","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1038\/sj.npp.1300551","article-title":"Prefrontal neuropsychological predictors of treatment remission in late-life depression","volume":"29","author":"Potter","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0210","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.bbi.2009.07.001","article-title":"Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality","volume":"23","author":"Prather","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0215","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.biopsych.2008.08.010","article-title":"Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression","volume":"65","author":"Raison","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0220","article-title":"Interferon-alpha effects on diurnal hypothalamic\u2013pituitary\u2013adrenal axis activity: relationship with proinflammatory cytokines and behavior","author":"Raison","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0225","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/mp.2008.58","article-title":"Interferon-alpha effects on diurnal hypothalamic\u2013pituitary\u2013adrenal axis activity: relationship with proinflammatory cytokines and behavior","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0230","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2005.11.006","article-title":"Cytokines sing the blues: inflammation and the pathogenesis of depression","volume":"27","author":"Raison","year":"2006","journal-title":"Trends Immunol."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0235","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0240","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00023210-200519020-00002","article-title":"Neuropsychiatric adverse effects of interferon-alpha: recognition and management","volume":"19","author":"Raison","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0245","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0250","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.biopsych.2010.04.019","article-title":"Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol","volume":"68","author":"Raison","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0255","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1046\/j.1365-2796.2000.00603.x","article-title":"The hypothalamic\u2013pituitary\u2013adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke","volume":"247","author":"Rosmond","year":"2000","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0260","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.psyneuen.2015.01.010","article-title":"Diurnal cortisol and survival in epithelial ovarian cancer","volume":"53","author":"Schrepf","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0265","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/jnci\/92.12.994","article-title":"Diurnal cortisol rhythm as a predictor of breast cancer survival.[see comment]","volume":"92","author":"Sephton","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0270","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/vim.2005.18.41","article-title":"Immune modulation of the hypothalamic\u2013pituitary\u2013adrenal (HPA) axis during viral infection","volume":"18","author":"Silverman","year":"2005","journal-title":"Viral Immunol."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbi.2014.10.012","article-title":"Understanding inflammation, its regulation, and relevance for health: a top scientific and public priority","volume":"45","author":"Slavich","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0280","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","article-title":"The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue","volume":"39","author":"Smets","year":"1995","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0285","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.mad.2004.06.010","article-title":"Mechanisms of glucocorticoid receptor signaling during inflammation","volume":"125","author":"Smoak","year":"2004","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0290","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.psyneuen.2006.09.004","article-title":"Stress sensitivity in metastatic breast cancer: analysis of hypothalamic\u2013pituitary\u2013adrenal axis function","volume":"31","author":"Spiegel","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0295","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/(SICI)1097-0215(19960301)65:5<591::AID-IJC6>3.0.CO;2-Y","article-title":"The pattern of hormonal circadian time structure (acrophase) as an assessor of breast-cancer risk","volume":"65","author":"Ticher","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0300","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.steroids.2011.04.018","article-title":"Interleukins 1alpha and 1beta as regulators of steroidogenesis in human NCI-H295R adrenocortical cells","volume":"76","author":"Tkachenko","year":"2011","journal-title":"Steroids"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0305","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/cncr.28003","article-title":"Predictors of depression in breast cancer patients treated with radiation: role of prior chemotherapy and nuclear factor kappa B","volume":"119","author":"Torres","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0310","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","article-title":"Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial","volume":"367","author":"Tyring","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0315","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2007.05.015","article-title":"Glucocorticoids, metabolism and metabolic diseases","volume":"275","author":"Vegiopoulos","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.physbeh.2015.12.013_bb0320","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.mp.4001339","article-title":"Interleukin 1alpha (IL-1alpha) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function","volume":"9","author":"Wang","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.physbeh.2015.12.013_bb0325","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/7854_2012_211","article-title":"Inflammation and depression","volume":"14","author":"Zunszain","year":"2013","journal-title":"Curr. Top. Behav. Neurosci."}],"container-title":["Physiology &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938415302109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938415302109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T16:50:42Z","timestamp":1537116642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938415302109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":65,"alternative-id":["S0031938415302109"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2015.12.013","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-alpha-induced inflammation is associated with reduced glucocorticoid negative feedback sensitivity and depression in patients with hepatitis C virus","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2015.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}